Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Samsung Electronics (005930) – Decision on Overseas Stock Exchange Listing / 2024-10-31 Semiconductors
  • [Research] Samsung Electro-Mechanics (009150) – DS Investment & Securities | AI Server · High-Value MLCC · FC-BGA Supply Expansion / 2025-08-01 RESEARCH
  • [Disclosure] Hanwha Systems (272210) – Setting of Record Date for Shareholders / 2024-09-02 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract (Correction) / 2024-06-07 Disclosures
  • [Disclosure] Celltrion (068270) – Application for Phase 3 Clinical Trial Plan for CT-P55 (Cosentyx Biosimilar) in Europe (Part 1 & 2) / 2024-10-14 Bio & Healthcare
  • [Disclosure] Hana Micron (067310) – Decision on Cash/In-Kind Dividend / 2026-03-10 Semiconductors
  • [Disclosure] Hana Micron (067310) – Investor Relations (IR) Holding / 2025-07-02 Semiconductors
  • [Disclosure] Celltrion (068270) – Decision on Capital Increase by Rights Offering (Major Management Matters of Subsidiary) / 2025-12-11 Disclosures

[Disclosure] ALTEOGEN (196170) – Submission of Audit Report / 2025-03-21

Posted on March 25, 2025August 5, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART

💡 3-Second Summary

Alteogen submitted its audit report audited by Samil PricewaterhouseCoopers with ‘Unqualified’ opinions for both consolidated and separate financial statements, successfully turning both operating income and net income into profitability.

📊 [Key Disclosure Details & Financial Highlights]

  • External Auditor: Samil PricewaterhouseCoopers
  • Date of Audit Report Receipt: 2025-03-21
  • Audit Opinion: Consolidated ‘Unqualified’ / Separate ‘Unqualified’
  • Going Concern Uncertainty: Not Applicable
  • Consolidated Financial Highlights (Unit: KRW):
    • Total Assets: KRW 409.01B (Previous Year: KRW 256.10B)
    • Total Liabilities: KRW 134.92B (Previous Year: KRW 108.26B)
    • Total Equity: KRW 274.09B (Previous Year: KRW 147.84B)
    • Capital Stock: KRW 26.66B
    • Revenue: KRW 102.85B (Previous Year: KRW 96.52B)
    • Operating Profit: KRW 25.40B (Previous Year: Loss of KRW 9.74B, Turnaround to Profit)
    • Net Income: KRW 60.69B (Previous Year: Net Loss of KRW 3.58B, Turnaround to Profit)
  • Separate Financial Highlights (Unit: KRW):
    • Total Assets: KRW 331.65B
    • Total Liabilities: KRW 30.52B
    • Total Equity: KRW 301.13B
    • Revenue: KRW 92.97B
    • Operating Profit: KRW 30.63B (Previous Year: Loss of KRW 0.90B, Turnaround to Profit)
    • Net Income: KRW 71.23B
  • Delisting Requirement Checks: Capital Impairment Ratio N/A, Impairment Loss Ratio over 50% No

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Confirmation of Turnaround Earnings at Shareholders Meeting and Detailed Notes in Annual Report

This audit report filing officially verifies the auditor’s ‘Unqualified’ opinion along with consolidated revenue surpassing KRW 100B and a successful turnaround in both operating income and net income. Verifying whether these figures are finalized without changes through the annual general meeting approval is important to confirm the absolute integrity of the official financial data. Full details on financial statements and detailed auditor’s notes can be reviewed in the ‘Annual Report’ submitted following the shareholders meeting approval.

📢 Disclaimer & Source Information

Source: This content was structured and generated based on official submission data from the Financial Supervisory Service’s Data Analysis, Retrieval and Transfer System (DART).

Investment Risk Warning: This content is provided solely for informational and linguistic reference purposes. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest entirely with the investor.

Contact: For inquiries regarding regulatory compliance or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Disclosures, Bio & Healthcare

Post navigation

Previous Post: [Disclosure] Hanwha Systems (272210) – (Correction) Sales / Supply Contract / 2025-03-25
Next Post: [Disclosure] Hana Micron (067310) – Investor Relations (IR) Holding / 2025-03-25

Related Posts

  • [Disclosure] Hanwha Aerospace (012450) – Advance Notice of Unfaithful Disclosure Company Designation / 2025-04-09 Disclosures
  • [Disclosure] Celltrion (068270) – CT-P55 (Cosentyx Biosimilar) U.S. BLA Submission / 2026-07-30 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Paid-in Capital Increase Decision of Subsidiary / 2025-02-18 Disclosures
  • [Disclosure] Samsung Electro-Mechanics (009150) – Investor Relations (IR) Schedule Announcement / 2024-04-11 Semiconductors
  • [Disclosure] Hanwha Aerospace (012450) – Trading Suspension and Resumption of Stock Futures / 2024-04-05 Disclosures
  • [Disclosure] ALTEOGEN (196170) – Results of Annual General Meeting of Shareholders / 2026-03-31 Disclosures
  • [Disclosure] Hyundai Motor (005380) – Decision on Closure of Shareholders’ Register (Record Date) for Cash and In-Kind Dividend / 2025-04-24 Disclosures
  • [Disclosure] Hanwha Systems (272210) – Sales/Supply Contract / 2024-03-27 Disclosures
  • [Disclosure] Hyundai Motor (005380) – Results of Annual General Meeting of Shareholders / 2026-03-26 Disclosures
  • [Disclosure] SK square (402340) – Decision on Acquisition of Treasury Shares / 2025-11-13 Disclosures
  • [Disclosure] Hanwha Aerospace(012450) – Investor Relations (IR) Holding Announcement / 2024-07-17 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Provisional Financial Results (Consolidated) / 2026-07-31 Disclosures
  • [Disclosure] ALTEOGEN (196170) – Board Resolution on Convening Extraordinary General Shareholders Meeting / 2024-11-18 Disclosures
  • [Disclosure] Hana Micron (067310) – (Correction) Decision on Closure of Shareholders’ Register (Record Date) for Cash and In-Kind Dividend / 2024-12-16 Semiconductors

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme